Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 3:13:825338.
doi: 10.3389/fmicb.2022.825338. eCollection 2022.

Recent Advances in Understanding the Structure and Function of the Human Microbiome

Affiliations
Review

Recent Advances in Understanding the Structure and Function of the Human Microbiome

Walaa K Mousa et al. Front Microbiol. .

Abstract

Trillions of microbes live within our bodies in a deep symbiotic relationship. Microbial populations vary across body sites, driven by differences in the environment, immunological factors, and interactions between microbial species. Major advances in genome sequencing enable a better understanding of microbiome composition. However, most of the microbial taxa and species of the human microbiome are still unknown. Without revealing the identity of these microbes as a first step, we cannot appreciate their role in human health and diseases. A shift in the microbial balance, termed dysbiosis, is linked to a broad range of diseases from simple colitis and indigestion to cancer and dementia. The last decade has witnessed an explosion in microbiome research that led to a better understanding of the microbiome structure and function. This understanding leads to potential opportunities to develop next-generation microbiome-based drugs and diagnostic biomarkers. However, our understanding is limited given the highly personalized nature of the microbiome and its complex and multidirectional interactions with the host. In this review, we discuss: (1) our current knowledge of microbiome structure and factors that shape the microbial composition, (2) recent associations between microbiome dysbiosis and diseases, and (3) opportunities of new microbiome-based therapeutics. We analyze common themes, promises, gaps, and challenges of the microbiome research.

Keywords: disease associations; fecal transplant; human microbiome; microbial diversity; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Major factors shaping the microbiome diversity. Illustrated are examples of multiple overlapping factors that shape the microbial composition including diet, stress, diseases, drugs, lifestyle, age, and host genetics. The outcome of these interacting factors are either healthy diverse, imbalanced, or dysbiotic microbiome which in turn affects the host health and diseases.
Figure 2
Figure 2
Microbiome and diseases association. Illustrated are examples of health and disease conditions that are linked to change in the microbiome. Health conditions associated with healthy microbiome include, as examples, protection from infections and radiation resistance. Diseases that result from imbalanced microbiomes are countless and include drug resistance, mental disorders, social diseases, obesity and metabolic syndrome, and sleep disorders.
Figure 3
Figure 3
Microbiome-secreted molecules and their effect on human health and diseases. The first panel of the Illustration shows some examples of well-defined secreted molecules that affects human health including (1) short-chain fatty acids (SCFAs) such as butyrate which play anti-inflammatory role and modulate the intestinal immunity and (2) lugdunin as an example to microbiome-based antibiotic produced by nose microbiome and target Staphyloccous. The second panel shows examples of microbiome-based metabolites that are associated with onset or development of diseases including: (1) trimethylamine N-oxide (TMAO)/cardiovascular diseases, (2) 4-ethylphenylsulphate/autism, and (3) colibactin/colorectal cancer.

References

    1. Abdulla M.-H., Agarwal D., Singh J. K., Traiki T. B., Pandey M. K., Ahmad R., et al. . (2021). Association of the microbiome with colorectal cancer development (review). Int. J. Oncol. 58:17. doi: 10.3892/ijo.2021.5197, PMID: - DOI - PubMed
    1. Abee T., Klaenhammer T. R., Letellier L. (1994). Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane. Appl. Environ. Microbiol. 60, 1006–1013. doi: 10.1128/aem.60.3.1006-1013.1994, PMID: - DOI - PMC - PubMed
    1. Agrawal R., Ajami N. J., Malhotra S., Chen L., White D. L., Sharafkhaneh A., et al. . (2021). Habitual sleep duration and the colonic mucosa-associated gut microbiota in humans—a pilot study. Clocks Sleep 3, 387–397. doi: 10.3390/clockssleep3030025, PMID: - DOI - PMC - PubMed
    1. Ait-Belgnaoui A., Durand H., Cartier C., Chaumaz G., Eutamene H., Ferrier L., et al. . (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885–1895. doi: 10.1016/j.psyneuen.2012.03.024, PMID: - DOI - PubMed
    1. Al-Azemi M., Raghupathy R., Azizieh F. (2017). Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction. Clin. Exp. Obstet. Gynecol. 44, 98–103. doi: 10.12891/ceog3295.2017, PMID: - DOI - PubMed

LinkOut - more resources